Page 455 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 455

Hematology and oncology   ` hematology and oncology—PhySIology  Hematology and oncology   ` hematology and oncology—PhySIology  SectIon III  411




                  Platelet plug formation (primary hemostasis)
                                                                                4A                       4B
                     INJURY           EXPOSURE         ADHESION           ACTIVATION       AGGREGATION
                     Endothelial damage   vWF binds to exposed   Platelets bind vWF via GpIb   ADP binding to P2Y 12    Fibrinogen binds GpIIb/IIIa receptors and links platelets
                     → transient      collagen         receptor at the site of injury   receptor induces GpIIb/IIIa   Balance between
                     vasoconstriction via   vWF is from Weibel-Palade   only (specific)   platelets   expression at platelet
                     neural stimulation reflex   bodies of endothelial   undergo conformational   surface    Pro-aggregation factors:   Anti-aggregation factors:
                     and endothelin (released   cells and α-granules of   change           TXA 2  (released  PGI 2  and NO (released
                     from damaged cell)  platelets                                         by platelets)   by endothelial cells)
                                                                                           ↓ blood flow     ↑ blood flow
                                                       Platelets release ADP and           ↑ platelet aggregation  ↓ platelet aggregation
                                                       Ca 2+  (necessary for
                                                       coagulation cascade), TXA 2
                                                                                           Temporary plug stops bleeding; unstable, easily dislodged
                                                       ADP helps platelets adhere
                                                       to endothelium                                        Coagulation cascade
                                                                                                             (secondary hemostasis)



                  Thrombogenesis                                                  Formation of insoluble fibrin mesh.
                                                                                  Aspirin irreversibly inhibits cyclooxygenase,
                                                                                   thereby inhibiting TXA  synthesis.
                                                                                                       2
                                                                                  Clopidogrel, prasugrel, and ticlopidine inhibit
                                                                                    ADP-induced expression of GpIIb/IIIa by
                                                                                    irreversibly blocking P2Y  receptor.
                                                                                                        12
                                                                                  Abciximab, eptifibatide, and tirofiban inhibit
                                                                                    GpIIb/IIIa directly.
                                                                                  Ristocetin activates vWF to bind GpIb. Failure
                                                                                    of aggregation with ristocetin assay occurs in
                                       Clopidogrel, prasugrel,
                                           ticlopidine         Platelet             von Willebrand disease and Bernard-Soulier
                                                           Inside  vWF              syndrome.
                                                 Aspirin  platelets               vWF carries/protects factor VIII; volksWagen
                                                                   Fibrinogen
                                                                                    Factories make gr8 cars.
                                               Fibrinogen          COX
                                                            Arachidonic
                                 ADP (P2Y 12 ) receptor                TXA 2
                                                                acid
                                                    4B
                                             4A
                                                                       Deficiency: Glanzmann thrombasthenia
                                                           GpIIb/IIIa
                                                                                Activated
                         Deficiency: Bernard-   GpIIb/IIIa  Abciximab,   Thrombin-  Protein C  protein C
                         Soulier syndrome       insertion  eptifibatide,   thrombomodulin   Vascular endothelial cells
                                                            tirofiban  complex
                                                        Deficiency: von
                                                        Willebrand                                Inside  (vWF + factor VIII)
                            Subendothelial  GpIb  vWF   disease                                endothelial  Thromboplastin
                              collagen                                                            cells
                                                                                                       tPA, PGI 2


























          FAS1_2019_10-HemaOncol.indd   411                                                                             11/7/19   5:04 PM
   450   451   452   453   454   455   456   457   458   459   460